Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma
- 15 February 2024
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 37 (3) , 714-728
Abstract
Tumor-infiltrating neutrophils play a crucial role in the progression of head and neck squamous cell carcinoma (HNSCC). Here, we aimed to statistically quantify the plasticity of HNSCC-infiltrating N2/N1 neutrophils and examine its impacts on survival and immune infiltration landscape. A retrospective study of 80 patients who underwent curative surgical resection for HNSCC between 2014 and 2017 was conducted in this study. HNSCC-infiltrating neutrophil phenotypes were classified using immunofluorescence staining, and the N2/N1 neutrophil plasticity was evaluated via the ratio of N2/N1 neutrophils. We then assessed the correlations between N2/N1 neutrophil plasticity, clinicopathological characteristics, and immune infiltration landscape using rigorous statistical methods. Infiltration variations of N1 and N2 neutrophils were observed between the tumor nest (TN) and tumor stroma (TS), with TN exhibiting higher N2 neutrophil infiltration and lower N1 neutrophil infiltration. High ratios of N2/N1 neutrophils were correlated with advanced TNM stage, large tumor size and invasion of adjacent tissue. High infiltration of N2 neutrophils was associated with decreased overall and relapse-free survival, which were opposite for N1 neutrophils. The independent prognostic role of N2/N1 neutrophil plasticity, particularly within the TN region, was confirmed by multivariate analyses. Moreover, the ratio of N2/N1 neutrophils within the TN region showed correlations with high CD8+ T cells infiltration and low FOXP3+ Tregs infiltration. We identify HNSCC-infiltrating N2/N1 neutrophil plasticity as a crucial prognostic indictor which potentially reflects the tumor microenvironment (TME) and immune escape landscape within HNSCC tissues. Further investigations and validations may provide novel therapeutic strategies for personalized immunomodulation in HNSCC patients.Keywords
Funding Information
- the Major Clinical Research Project of Shanghai Shen-kang Hospital Clinical Development Center (SHDC2020CR6011)
- the Science and Technology Innovation Project of Shanghai Shen-kang Hospital Clinical Development Center (SHDC12015114)
- The National Natural Science Foundation of China (81772878, 82003178)
- the Shanghai Municipal Key Clinical Specialty (shslczdzk00801)
- the Science and Technology Committee of Shanghai (20MC1920200)
- the Science and Technology Commission of Shanghai Municipality (20Y11902200)
- the Shanghai Anti-Cancer Development Foundation (H6001-008)
- the Training Program of the Excellent Doctors of Fudan University (QT00140)
This publication has 50 references indexed in Scilit:
- Neutrophils Suppress Intraluminal NK Cell–Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma CellsCancer Discovery, 2016
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and TreatmentMayo Clinic Proceedings, 2016
- The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancerThe EMBO Journal, 2015
- Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in CancerCell Reports, 2015
- NETosis: A New Factor in Tumor Progression and Cancer-Associated ThrombosisSeminars in Thrombosis and Hemostasis, 2014
- Neutrophils recruit regulatory T‐cells into tumors via secretion of CCL17—A new mechanism of impaired antitumor immunityInternational Journal of Cancer, 2014
- Tumor-associated neutrophils: friend or foe?Carcinogenesis, 2012
- Neutrophils promote motility of cancer cells via a hyaluronan‐mediated TLR4/PI3K activation loopThe Journal of Pathology, 2011
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapyEuropean Journal of Cancer, 2006